We demonstrated that the TG/HDL ratio, IL-2, IL-6, IL-17A, and INF-γ were significantly greater in subjects with MetS than in those without MetS, and may therefore be used as biomarkers to predict future cardiovascular disease. Here, IL2 is linked to cardiovascular disorder.